Improving the cost-to-benefit ratio in-vitro fertilization

Wisconsin Medical Journal

Volumn 96, Issue 1, 1997, Pages 36-39

  Silva, Paul D ^a   Sorensen, Michelle L ^a   Silva, Diane E ^b  

^a GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

^b Gundersen Clinic ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; IN VITRO STUDY; INFERTILITY; PREGNANCY;

CLINICAL PROTOCOLS; COST CONTROL; FEES AND CHARGES; FEMALE; FERTILIZATION IN VITRO; HUMANS; PROGRAM EVALUATION; RURAL HEALTH SERVICES; WISCONSIN;

EID: 0031032580     PISSN: 00436542     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Establishing priority for infertility services in health care reform. Washington, D.C.: American Fertility Society, Office of Government Relations, 1994.
2. Haan G: Effects and costs of invitro fertilization - again, let's be honest. Int J Tech Assess Health Care 1991; 7: 585-93.
3. Neumann PJ, Gharib SD, Weinstein MC: The cost of a successful delivery with in-vitro fertilization. N Engl J Med 1994; 331: 239-43.
4. Office of Technology Assessment. Evaluation of the Oregon Medicaid proposal. Washington, DC:US Government Printing Office, 1993.
5. Assisted reproductive technology in the United States and Canada: 1993 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 1995;64: 13-21.
6. Garcia JE, Padilla SL, Bayati J, et al: Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization. Fertil Steril 1990; 53:302-5.
7. Toth TL, Awwad JT, Veeck LL, et al: Suppression and flare regimens of gonadotropin releasing hormone agonist: use in women with different basal gonadotropin values in an in vitro fertilization program. J Reprod Med 1996;41:321-6.
8. Acharya U, Small J, Randall J, et al: Prospective study of short and long regimens of gonadotropin-releasing hormone agonist in in vitro fertilization program. Fertil Steril 1992;57:815-8.
9. Scott RT, Navot D: Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 1994;61:880-5.
10. Collins JA, Bustillo M, Visscher RD, et al: An estimate of the cost of in vitro fertilization services in the United States in 1995. Fertil Steril 1995;64:538-45.
11. Frankfurter D, DeCherney AH: Infertility treatment and the IVF patient in managed care settings. Am J Man Care 1996;2:691-6.
12. Neumann PJ, Johannesson M: The willingness to pay for in vitro fertilization: a pilot study using contingent valuation. Med Care 1994;32:686-99.